LISATA THERAPEUTICS, INC. Restricted Cash and Investments, Current
LISATA THERAPEUTICS, INC. (LSTA) had Restricted Cash and Investments, Current of $11.64 million as of 2019-12-31, per its 10-K filed 2020-03-05.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Restricted Cash and Investments, Current
us-gaap:RestrictedCashAndInvestmentsCurrent · last filed 2020-03-05
- 2019-12-31: Restricted Cash and Investments, Current $11.64M.
- 2018-12-31: Restricted Cash and Investments, Current $5.06M.
- 2017-12-31: Restricted Cash and Investments, Current $25.97M; Restricted Cash and Investments, Current as first filed $25.97M.
- 2016-12-31: Restricted Cash and Investments, Current $4.43M.
| Period end | Restricted Cash and Investments, Current | Restricted Cash and Investments, Current as first filed |
|---|---|---|
| 2019-12-31 | $11.64M 10-K · filed 2020-03-05 | |
| 2018-12-31 | $5.06M 10-K · filed 2020-03-05 | |
| 2017-12-31 | $25.97M 10-K · filed 2019-03-14 | $25.97M 10-K · filed 2018-03-22 |
| 2016-12-31 | $4.43M 10-K · filed 2018-03-22 | |
| 2015-12-31 | $6.88M 10-K · filed 2017-03-17 | |
| 2014-12-31 | $15.28M 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |